By mimicking the action of the hormone GLP-1, Semaglutide activates receptors in the brain that regulate appetite and satiety
Interest in glucagon-like peptide 1 receptor agonists (GLP-1s) continues to surge due to their effectiveness in reducing body weight and improving metabolic outcomes
What Medical Sources Say About Berberine And GLP-1 Medications Medical literature highlights caution rather than endorsement
Some practitioners experiment with dose reduction to 1.7mg or 1.0mg after reaching goal weight, but this lacks formal study
At USD 1,349 per month list price for Wegovy and USD 1,059 for Zepbound, monthly GLP-1 obesity drug costs create absolute financial barriers for the 62% of obesity patients enrolled in Medicaid, Medicare, or underinsured commercial plans without anti-obesity medication benefits
Hormonal fluctuations during perimenopause can make weight management particularly challenging because they can affect appetite regulation